France
· Delayed Price · Currency is EUR UV Germi Statistics
Total Valuation
UV Germi has a market cap or net worth of EUR 7.54 million. The enterprise value is 3.37 million.
| Market Cap | 7.54M |
| Enterprise Value | 3.37M |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UV Germi has 3.18 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 2.96% |
| Float | 1.02M |
Valuation Ratios
The trailing PE ratio is 10.62.
| PE Ratio | 10.62 |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.75 |
| EV / Sales | 0.38 |
| EV / EBITDA | 3.93 |
| EV / EBIT | 6.73 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.44, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.44 |
| Quick Ratio | 5.50 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | n/a |
| Interest Coverage | 410.37 |
Financial Efficiency
Return on equity (ROE) is 7.48% and return on invested capital (ROIC) is 3.26%.
| Return on Equity (ROE) | 7.48% |
| Return on Assets (ROA) | 2.92% |
| Return on Invested Capital (ROIC) | 3.26% |
| Return on Capital Employed (ROCE) | 5.03% |
| Revenue Per Employee | 203,334 |
| Profits Per Employee | 16,135 |
| Employee Count | 46 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.15% in the last 52 weeks. The beta is -0.24, so UV Germi's price volatility has been lower than the market average.
| Beta (5Y) | -0.24 |
| 52-Week Price Change | -34.15% |
| 50-Day Moving Average | 2.52 |
| 200-Day Moving Average | 2.78 |
| Relative Strength Index (RSI) | 44.58 |
| Average Volume (20 Days) | 2,539 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, UV Germi had revenue of EUR 8.95 million and earned 709,927 in profits.
| Revenue | 8.95M |
| Gross Profit | 4.08M |
| Operating Income | 501,474 |
| Pretax Income | 571,805 |
| Net Income | 709,927 |
| EBITDA | 857,977 |
| EBIT | 501,474 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 4.26 million in cash and 91,992 in debt, giving a net cash position of 4.16 million or 1.31 per share.
| Cash & Cash Equivalents | 4.26M |
| Total Debt | 91,992 |
| Net Cash | 4.16M |
| Net Cash Per Share | 1.31 |
| Equity (Book Value) | 9.88M |
| Book Value Per Share | n/a |
| Working Capital | 8.10M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 45.64%, with operating and profit margins of 5.61% and 7.94%.
| Gross Margin | 45.64% |
| Operating Margin | 5.61% |
| Pretax Margin | 6.39% |
| Profit Margin | 7.94% |
| EBITDA Margin | 9.59% |
| EBIT Margin | 5.61% |
| FCF Margin | n/a |
Dividends & Yields
UV Germi does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.21% |
| Shareholder Yield | 0.21% |
| Earnings Yield | 9.42% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |